Dear Colleague
The first update of concessionary prices were granted today for September 2024:
DrugPack SizeConcessionary Price
Benzydamine 0.15% mouthwash sugar free300£4.51
Clomipramine 50mg capsules28£7.99
Clotrimazole 1% cream50£3.49
Co-codamol 15mg/500mg tablets100£3.29
Co-tenidone 50mg/12.5mg tablets28£6.30
Docusate 50mg/5ml oral solution sugar free300£17.12
Duloxetine 20mg gastro-resistant capsules28£7.78
Duloxetine 40mg gastro-resistant capsules56£8.66
Enalapril 10mg tablets28£0.94
Escitalopram 10mg tablets28£1.65
Estradiol 10microgram pessaries24£9.90
Glimepiride 4mg tablets30£1.20
Isotretinoin 20mg capsules30£10.27
Losartan 12.5mg tablets28£2.19
Memantine 20mg tablets28£1.69
Metformin 1g modified-release tablets56£3.65
Metformin 500mg/5ml oral solution sugar free150£22.45
Methylphenidate 10mg tablets30£3.25
Mometasone 50micrograms/dose nasal spray140£7.68
Morphine sulfate 10mg/1ml solution for injection ampoules10£6.48
Mycophenolate mofetil 500mg tablets50£5.74
Nefopam 30mg tablets90£3.77
Nicorandil 10mg tablets60£8.99
Nicorandil 20mg tablets60£15.95
Nortriptyline 10mg tablets100£4.54
Olanzapine 15mg tablets28£3.70
Perindopril erbumine 2mg tablets30£2.15
Perindopril erbumine 4mg tablets30£2.59
Perindopril erbumine 8mg tablets30£4.75
Pregabalin 100mg capsules84£2.39
Pregabalin 150mg capsules56£2.65
Pregabalin 200mg capsules84£4.65
Pregabalin 225mg capsules56£2.50
Pregabalin 50mg capsules84£13.45
Quetiapine 200mg tablets60£18.79
Quetiapine 25mg tablets60£4.00
Sevelamer 800mg tablets180£26.49
Sodium cromoglicate 2% eye drops13.5£3.14
Sodium valproate 200mg/5ml oral solution sugar free300£8.45
Tacrolimus 0.1% ointment30£25.92
Tacrolimus 0.1% ointment60£47.28
Tadalafil 5mg tablets28£1.89
Tamoxifen 20mg tablets30£2.37
Telmisartan 80mg tablets28£17.00
Temazepam 10mg tablets28£24.69

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Shortage Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive

Dear colleague,

Following on from CU#240910A you will be aware that on Thursday 19th of September 2024, the NPA is holding a second day of protest for community pharmacies across the four nations – to call for a fair deal for the sector.

Community pharmacies in Northern Ireland showed a high level of support in the previous day of action in June.

To build on this momentum, the NPA has once again invited pharmacy bodies from across the UK to share information about the day with their own members.

On the day, they are asking pharmacies to:

  • Ring bells, blow a whistle or make other noises for two minutes from 9am, to sound the alarm about the crisis being faced by pharmacy;
  • Share on social media!  Use the hashtag #saveourpharmacies;
  • Turn off the lights between 9am-12noon;
  • Ask your teams to wear black;
  • Black out the windows.

The day of action is open to all community pharmacies across the UK.

Further information is available here.

CPNI supports this NPA day of action to #saveourpharmacies and we have been liaising with the NPA in relation to this.  We would encourage you and your teams to participate in it on Thursday 19th September 2024.

We will be sharing Northern Ireland specific social media cards which you are invited to add to your own social media channels.

Please do not hesitate to contact your NPA representative or Jude Austin at judea@communitypharmacyni.co.uk if you require any further information.

Kind regards,

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
This update contains important information for community pharmacy teams.

CPNI ALERTS

DOH(NI) ALERTS

BSO ALERTS

NPA DAY OF ACTION ON 19th SEPTEMBER 2024

On Thursday 19th of September 2024, NPA are holding a second day of protest for community pharmacies across the four nations – to call for a fair deal for the sector.  For more information click here.

Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.
Or report medicine shortages, pricing and staffing issues via CPNI’s Medicine Shortage Reporter and Situation Reporter.
Please bring this to the attention of your pharmacy team(s).

Kind regards

SENT ON BEHALF OF
Gerard Greene
Chief Executive
Dear Contractor
Please see attached correspondence from Professor Sir Michael McBride, Chief Medical Officer, regarding the Autumn 2024 influenza vaccination programme.

SUMMARY

  • The correspondence details:
    • The eligible cohorts for influenza vaccination in line with the recommendations of the JCVI.
    • Community Pharmacy will play an important role in the vaccination of frontline HSC workers, patients aged 65 and over, carers, and those who are pregnant.
    • Community Pharmacy will also be able to offer influenza vaccination to all RQIA-registered care home residents and staff as part of this year’s seasonal influenza programme.
    • Community Pharmacists and those frontline staff involved in supplying medicines will be able to receive the vaccine from participating Community Pharmacies offering influenza vaccination services
    • The Movianto web-based ordering system is available to all Community Pharmacies and will facilitate simple and accurate ordering of all centrally procured seasonal influenza vaccines for the forthcoming 2024/2025 immunisation campaign.
    • The Strategic Planning and Performance Group (SPPG) will notify community pharmacies contracted to deliver the influenza vaccination programme of ordering arrangements.

ACTION

  • Contractors are asked to review the correspondence issued 13th September 2024 regarding the seasonal influenza vaccination programme.
  • SPPG are finalising the service documentation and we expect it to be issued imminently.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
REMINDER: For the attention of Community Pharmacies involved in Rota Service
Dear Contractor,

CPNI is asking those pharmacies involved in rota service to complete this data collection form.

Please return the form via email to the CPNI office   (info@communitypharmacyni.co.uk) each time you complete a rota session.

CPNI will use the information gathered to help inform rota services going forward.

Your assistance with this matter would be greatly appreciated.

Kind Regards,

SENT ON BEHALF OF
GERARD GREENE
Chief Executive

Dear Contractor

The Department of Health NI has issued correspondence dated 10 September 2024 giving details of serious shortage protocols SSP073, SSP074, SSP075 and SSP076 relating to isosorbide mononitrate 60mg preparations.

These SSPs are due to expire on various dates between 27 September 2024 and 17 January 2025.

BACKGROUND

  • SSPs made under the Human Medicines Regulations 2012 are an additional tool to manage and mitigate medicines shortages.
  • SSPs enable community pharmacists to supply specified medicines in accordance with a protocol rather than a prescription, without needing to seek authorisation from the prescriber – saving time for patients, pharmacists and prescribers.
  • Pharmacists should refer to the latest versions of the existing SSPs which are now available on the Business Services Organisation dedicated page on its website.
  • Operational guidance on the implementation of SSPs in Northern Ireland can be found on the BSO website.

ACTION

Contractors should ensure that their dispensary teams are aware of this update and particularly note:

  • The issuing of serious shortage protocols SSP073 – SSP076 for isosorbide mononitrate 60mg tablets;
  • That the letter provides a table outlining the SSPs, the medicine affected, the expiry dates and alternative products to be supplied;
  • That the letter also outlines the key points for these SSPs and that the full SSPs are available on the Business Services Organisation dedicated page on its website;
  • The guidance relating to the decision pathways for SSPs; notification of GPs; the need for patient/carer agreement, and action to take when this is not given; professional judgement; and actions regarding unclear quantities.

Contractors should contact their local SPPG office in the first instance should further information be required. CPNI colleagues are also available for assistance.

Kind regards

Mike

SENT ON BEHALF OF
PROF MIKE MAWHINNEY
Head of Regulatory Affairs